Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
about
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@ast
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@en
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@nl
type
label
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@ast
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@en
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@nl
prefLabel
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@ast
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@en
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@nl
P2093
P2860
P3181
P1476
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
@en
P2093
P2860
P304
P3181
P356
10.6004/JADPRO.2015.6.2.3
P407
P577
2015-01-01T00:00:00Z